Medications for Both Depression and Insomnia
Sedating antidepressants, particularly mirtazapine, trazodone, and doxepin, are the most appropriate medications for treating both depression and insomnia simultaneously. 1
First-Line Options
Mirtazapine
- Dosage: Start with 7.5-15 mg at bedtime, may increase to 30 mg
- Mechanism: 5-HT2 receptor antagonist with strong sedative properties
- Benefits:
- Promotes sleep, appetite, and weight gain
- Well-tolerated in most patients
- Improves both depression and insomnia symptoms
- Considerations: Weight gain may be significant in some patients 1
Doxepin
- Dosage: 3-6 mg at bedtime for insomnia; higher doses (25-150 mg) for depression
- Benefits:
- FDA-approved for insomnia at low doses (3-6 mg)
- Effective for sleep maintenance insomnia
- Antidepressant effects at higher doses
- Caution: More anticholinergic effects than other options 1
Trazodone
- Dosage: 50-100 mg at bedtime
- Benefits:
- Commonly used for insomnia in depressed patients
- Little to no anticholinergic activity
- Can be used as adjunct to other antidepressants
- Note: While the AASM suggests against trazodone for insomnia alone (at 50 mg), it is commonly prescribed and effective when insomnia occurs with depression 1, 2
Decision Algorithm
Assess predominant symptom pattern:
- If sleep maintenance is the primary insomnia complaint → Consider doxepin or mirtazapine
- If sleep onset is the primary complaint → Consider trazodone or mirtazapine
- If weight loss is concerning → Mirtazapine may be beneficial
- If weight gain is concerning → Trazodone may be preferable
Consider specific depression characteristics:
- For depression with anxiety → Mirtazapine often beneficial
- For depression with decreased appetite → Mirtazapine preferred
- For depression with significant daytime fatigue → Lower doses of these medications are advised
Important Clinical Considerations
Combination therapy: If using an SSRI or SNRI for depression that worsens insomnia, adding low-dose trazodone at bedtime is a common and effective strategy 1, 2
Avoid benzodiazepines and Z-drugs for long-term management of comorbid depression and insomnia, as they don't address the underlying depression and carry risks of tolerance and dependence 1
Cognitive Behavioral Therapy for Insomnia (CBT-I) should be considered alongside medication, as it enhances outcomes for both conditions 3
Monitor closely for suicidality, especially in younger patients, during the first few weeks of antidepressant treatment 4
Special Populations
- Elderly patients: Start with lower doses (e.g., mirtazapine 7.5 mg, trazodone 25-50 mg)
- Patients with recurrent depression: May have more pronounced sleep disturbances requiring more aggressive treatment 2
- Patients with childhood-onset depression and insomnia: May be more difficult to treat and require more intensive interventions 5
Common Pitfalls to Avoid
Using non-sedating antidepressants alone in patients with significant insomnia (e.g., SSRIs like sertraline, fluoxetine) as they may worsen sleep problems initially 1, 2
Overlooking the bidirectional relationship between insomnia and depression - treating insomnia often improves depression outcomes 3
Using over-the-counter sleep aids (antihistamines, melatonin) which lack efficacy data for comorbid depression and insomnia 1
Failing to reassess both depression and insomnia symptoms regularly to adjust treatment as needed
By targeting both conditions simultaneously with a sedating antidepressant, you can improve patient adherence, quality of life, and overall treatment outcomes.